BlackRock Investment Management, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 22 filers reported holding RECRO PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2016$11,000
-8.3%
1,3110.0%0.00%
Q3 2016$12,000
+33.3%
1,311
+22.2%
0.00%
Q2 2016$9,000
+80.0%
1,073
+29.9%
0.00%
Q1 2016$5,000
-28.6%
8260.0%0.00%
Q4 2015$7,000
-22.2%
826
+10.6%
0.00%
Q3 2015$9,000
-10.0%
7470.0%0.00%
Q2 2015$10,000
+66.7%
747
+11.2%
0.00%
Q1 2015$6,000
+200.0%
672
-14.5%
0.00%
Q4 2014$2,0000.0%7860.0%0.00%
Q3 2014$2,000
-66.7%
7860.0%0.00%
Q2 2014$6,0007860.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders